L-796,778

CAS No. 217480-25-6

L-796,778( —— )

Catalog No. M34635 CAS No. 217480-25-6

L-796,778 is an SST3 agonist and a selective ligand of SST3, which can increase the level of cAMP in the body.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 426 Get Quote
10MG 625 Get Quote
25MG 908 Get Quote
50MG 1270 Get Quote
100MG 1701 Get Quote
500MG 3402 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    L-796,778
  • Note
    Research use only, not for human use.
  • Brief Description
    L-796,778 is an SST3 agonist and a selective ligand of SST3, which can increase the level of cAMP in the body.
  • Description
    L-796,778 is an SST3 agonist and a selective ligand of SST3, which can increase the level of cAMP in the body.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Somatostatin Receptor
  • Recptor
    Somatostatin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    217480-25-6
  • Formula Weight
    584.66
  • Molecular Formula
    C29H40N6O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](CC1=CC=CC=C1)(C(NC2=CC=C(N(=O)=O)C=C2)=O)NC(N[C@@H](C(N[C@@H](CCCCN)C(OC)=O)=O)CCCC)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Octreotide acetate

    An octapeptide that mimics natural somatostatin pharmacologically, that is 200 times more potent than somatostatin.

  • Paltusotine

    Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients

  • CH 275

    Potent somatostatin receptor 1 (sst1) agonist; displays selectivity for sst1 (IC50 values are 30.9 nM, 345 nM, > 1 μM, > 10 μM and > 10μM for human sst1, sst3, sst4, sst2 and sst5 respectively). Attenuates somatostatin release in the rat nucleus accumbens.